Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Maria Gabriella Matera, Barbara Rinaldi, Carmela Belardo & Mario Cazzola. (2022) Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview. Expert Review of Clinical Pharmacology 15:11, pages 1269-1281.
Read now
Read now
Articles from other publishers (5)
Claus F. Vogelmeier, Heinrich Worth, Roland Buhl, Carl-Peter Criée, Eva Gückel & Peter Kardos. (2022) Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study. Respiratory Research 23:1.
Crossref
Crossref
Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2022) Dual bronchodilation for the treatment of COPD: From bench to bedside. British Journal of Clinical Pharmacology 88:8, pages 3657-3673.
Crossref
Crossref
François Maltais, Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Paul W. Jones, Isabelle H. Boucot, David A. Lipson, Lee Tombs, Chris Compton & Ian P. Naya. (2022) Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD. Respiratory Medicine 200, pages 106918.
Crossref
Crossref
Sun Hye Shin, Deog Kyeom Kim, Sang-Heon Kim, Tae Rim Shin, Ki-Suck Jung, Kwang Ha Yoo, Ki-Eun Hwang, Hye Yun Park & Yong Suk Jo. (2022) Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease. Journal of Personalized Medicine 12:6, pages 916.
Crossref
Crossref
A. I. Sinopalnikov. (2021) Pharmacotherapeutic strategy for COPD patients: focus on dual bronchodilators. Meditsinskiy sovet = Medical Council:16, pages 38-44.
Crossref
Crossref